Invesco’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $584K | Buy |
44,861
+9,965
| +29% | +$130K | ﹤0.01% | 3092 |
|
|
2025
Q1 | $370K | Buy |
34,896
+15,836
| +83% | +$168K | ﹤0.01% | 3268 |
|
|
2024
Q4 | $323K | Buy |
19,060
+225
| +1% | +$3.82K | ﹤0.01% | 3374 |
|
|
2024
Q3 | $437K | Buy |
18,835
+156
| +0.8% | +$3.62K | ﹤0.01% | 3277 |
|
|
2024
Q2 | $455K | Sell |
18,679
-1,273
| -6% | -$31K | ﹤0.01% | 3296 |
|
|
2024
Q1 | $674K | Buy |
19,952
+6,696
| +51% | +$226K | ﹤0.01% | 3174 |
|
|
2023
Q4 | $418K | Sell |
13,256
-120,315
| -90% | -$3.79M | ﹤0.01% | 3301 |
|
|
2023
Q3 | $3.41M | Buy |
133,571
+122,953
| +1,158% | +$3.14M | ﹤0.01% | 2389 |
|
|
2023
Q2 | $305K | Buy |
10,618
+734
| +7% | +$21.1K | ﹤0.01% | 3478 |
|
|
2023
Q1 | $237K | Sell |
9,884
-15,462
| -61% | -$371K | ﹤0.01% | 3557 |
|
|
2022
Q4 | $430K | Sell |
25,346
-988
| -4% | -$16.8K | ﹤0.01% | 3326 |
|
|
2022
Q3 | $391K | Buy |
26,334
+177
| +0.7% | +$2.63K | ﹤0.01% | 3357 |
|
|
2022
Q2 | $412K | Buy |
26,157
+4,417
| +20% | +$69.6K | ﹤0.01% | 3407 |
|
|
2022
Q1 | $586K | Buy |
21,740
+13,473
| +163% | +$363K | ﹤0.01% | 3275 |
|
|
2021
Q4 | $306K | Sell |
8,267
-1,326
| -14% | -$49.1K | ﹤0.01% | 3569 |
|
|
2021
Q3 | $459K | Buy |
9,593
+839
| +10% | +$40.1K | ﹤0.01% | 3437 |
|
|
2021
Q2 | $295K | Buy |
8,754
+3,079
| +54% | +$104K | ﹤0.01% | 3608 |
|
|
2021
Q1 | $234K | Buy |
+5,675
| New | +$234K | ﹤0.01% | 3621 |
|
|
2020
Q4 | – | Sell |
-8,414
| Closed | -$362K | – | 3728 |
|
|
2020
Q3 | $362K | Sell |
8,414
-212,490
| -96% | -$9.14M | ﹤0.01% | 3228 |
|
|
2020
Q2 | $10.3M | Buy |
+220,904
| New | +$10.3M | ﹤0.01% | 1609 |
|